Evidence map›Paper›PMID 27671338›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2016

Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.

Rafael Guerrero-Preston, Blanca L Valle, Anne Jedlicka, Nitesh Turaga, Oluwasina Folawiyo, Francesca Pirini, Fahcina Lawson, Angelo Vergura, Maartje Noordhuis, Amanda Dziedzic and 11 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06846775 recruitingnot on this mapstarted 2025, after this paper: background citation

A Case-control Study of the Clinical Utility of DNA Methylation Testing in Patient-collected Vaginal and Urine Samples: A Novel, Patient-friendly and Simple Diagnostic Solution to Detect Endometrial Cancer.

Typeobservational_patient_registrySponsorUniversity of AarhusRan2025 to 2028Enrolled120ConditionsEndometrial CancerArmsDNA-methylation testing in patient-collected urine and vaginal samples
NCT07400835 recruitingnot on this mapstarted 2026, after this paper: background citation

The ENDOMETRIAL Study: EvaluatioN of DNA methylatiOn Markers for EndomeTrial Cancer Risk-stratification Using Patient-collected urIne and vAginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal bLeeding

Typeobservational_patient_registrySponsorUniversity of AarhusRan2026 to 2030Enrolled600ConditionsPostmenopausal BleedingArmsDNA-methylation testing in patient-collected urine and vaginal samples and clinician-collected cervical samples
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Cancer prevention research (Philadelphia, Pa.) · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 1 institution in 1 country.

Rafael Guerrero-PrestonJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland. rguerre3@jhmi.edu dsidrans@jhmi.edu.
Blanca L ValleJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Anne JedlickaJohns Hopkins University School of Public Health, Department of Molecular Microbiology, Baltimore, Maryland.
Nitesh TuragaJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Oluwasina FolawiyoJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Francesca PiriniJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Fahcina LawsonJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Angelo VerguraJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Maartje NoordhuisJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Amanda DziedzicJohns Hopkins University School of Public Health, Department of Molecular Microbiology, Baltimore, Maryland.
Gabriela PérezJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Marisa RenehanJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Carolina Guerrero-DiazJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland.
Edgar De Jesus RodríguezUniversity of Puerto Rico School of Medicine, Department of Obstetrics and Gynecology, San Juan, Puerto Rico.
Teresa Diaz-MontesThe Institute for Cancer Care at Mercy, Department of Obstetrics and Gynecology, Baltimore, Maryland.
José Rodríguez OrengoUniversity of Puerto Rico School of Medicine, Department of Biochemistry, San Juan, Puerto Rico.
Keimari MéndezUniversity of Puerto Rico School of Medicine, Department of Obstetrics and Gynecology, San Juan, Puerto Rico.
Josefina RomagueraUniversity of Puerto Rico School of Medicine, Department of Obstetrics and Gynecology, San Juan, Puerto Rico.
Bruce J TrockJohns Hopkins School of Medicine, Brady Urological Institute, Baltimore, Maryland.
Liliana FloreaJohns Hopkins School of Medicine, McKusick-Nathans Institute of Genetic Medicine, Baltimore, Maryland.
David SidranskyJohns Hopkins University School of Medicine, Department of Otolaryngology, Baltimore, Maryland. rguerre3@jhmi.edu dsidrans@jhmi.edu.
Dialyse Centrum Groningen · NL

Funding

INTEGRATED DEVELOPMENT OF NOVEL MOLECULAR MARKERSU01CA084986 · NCI · JOHNS HOPKINS UNIVERSITY · PI SIDRANSKY, DAVID · 1999 to 2014
$33.8M
Epigenomic Markers of HNSCC Survival Across Ethnic GroupsK01CA164092 · NCI · JOHNS HOPKINS UNIVERSITY · PI GUERRERO-PRESTON, RAFAEL · 2011 to 2014
$530k
NCI NIH HHS K01 CA164092NCI NIH HHS U01 CA084986
6 · The paper itself

Abstract

Clinically useful molecular tools to triage women for a biopsy upon referral to colposcopy are not available. We aimed to develop a molecular panel to detect cervical intraepithelial neoplasia (CIN) grade 2 or higher lesions (CIN2

Indexed as

DNA MethylationAdolescentAdultAgedAged, 80 and overBiomarkers, TumorBiopsyCohort StudiesColposcopyDNA-Binding ProteinsDNA, ViralFemaleHuman papillomavirus 16Human Papillomavirus DNA TestsHumansMiddle AgedBiomarkers, TumorDNA-Binding ProteinsDNA, ViralFKBP6 protein, humanL1(deltaN26)-E7(deltaC38) protein, HPV16Tacrolimus Binding ProteinsVaccines, Virus-Like ParticleWnt1 ProteinWNT1 protein, humanZNF516 protein, human

Identifiers

PMID27671338
PMCPMC13616184
OpenAlexW2552721283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.